- Home
- MSI vs REGN Comparison
MSI vs REGN Comparison
Compare MSI & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSI
- REGN
- Stock Information
- Founded
- MSI 1928
- REGN 1988
- Country
- MSI United States
- REGN United States
- Employees
- MSI N/A
- REGN N/A
- Industry
- MSI Radio And Television Broadcasting And Communications Equipment
- REGN Biotechnology: Pharmaceutical Preparations
- Sector
- MSI Technology
- REGN Health Care
- Exchange
- MSI Nasdaq
- REGN Nasdaq
- Market Cap
- MSI 67.6B
- REGN 59.9B
- IPO Year
- MSI N/A
- REGN 1991
- Fundamental
- Price
- MSI $436.60
- REGN $558.87
- Analyst Decision
- MSI Strong Buy
- REGN Buy
- Analyst Count
- MSI 10
- REGN 21
- Target Price
- MSI $503.60
- REGN $823.86
- AVG Volume (30 Days)
- MSI 804.7K
- REGN 940.4K
- Earning Date
- MSI 08-07-2025
- REGN 08-01-2025
- Dividend Yield
- MSI 1.00%
- REGN 0.63%
- EPS Growth
- MSI 45.79
- REGN 5.03
- EPS
- MSI 11.91
- REGN 39.67
- Revenue
- MSI $10,956,000,000.00
- REGN $14,214,200,000.00
- Revenue This Year
- MSI $6.54
- REGN N/A
- Revenue Next Year
- MSI $5.64
- REGN $6.65
- P/E Ratio
- MSI $36.67
- REGN $14.09
- Revenue Growth
- MSI 7.45
- REGN 5.38
- 52 Week Low
- MSI $388.90
- REGN $476.49
- 52 Week High
- MSI $507.82
- REGN $1,211.20
- Technical
- Relative Strength Index (RSI)
- MSI 67.26
- REGN 54.16
- Support Level
- MSI $417.02
- REGN $541.61
- Resistance Level
- MSI $441.72
- REGN $563.59
- Average True Range (ATR)
- MSI 6.10
- REGN 15.37
- MACD
- MSI 1.89
- REGN -0.75
- Stochastic Oscillator
- MSI 84.54
- REGN 41.57
About MSI Motorola Solutions Inc.
Motorola Solutions is a leading provider of communications and analytics, primarily serving public safety departments as well as schools, hospitals, and businesses. The bulk of the firm's revenue comes from sales of land mobile radios and radio network infrastructure, but the firm also sells surveillance equipment and dispatch software. Most of Motorola's revenue comes from government agencies, while roughly 25% comes from schools and private businesses. Motorola has customers in over 100 countries and in every state in the United States.
About REGN Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).